免疫检查点抑制剂相关的神经肌肉事件的电生理学发现
E Lainez1, A Llauradó2, M Gratacòs-Viñola1
1Department of Clinical Neurophysiology. Vall d'Hebron University Hospital. Passeig de la Vall d'Hebron, 119 Barcelona, Spain.
概括
免疫检查点抑制剂 (ICI) 治疗可能导致神经肌肉疾病. 肌炎在ICI相关的严重肌炎/肌炎中很常见,而在神经病变中则是典型的脱髓性多基隆性神经病变. 早期的电诊断评估至关重要.
科学领域:
- 神经学
- 免疫学
- 癌症学
背景情况:
- 免疫检查点抑制剂 (ICI) 是恢复抗瘤免疫力的重要癌症疗法,但可能导致罕见的,严重的免疫相关不良事件 (irAEs).
- 影响神经,神经肌肉结节 (NMJ) 和肌肉的神经肌肉疾病是最常见的,并带有最高的死亡风险.
- 及时识别这些ICI相关的神经肌肉并发症对于患者的治疗至关重要.
研究的目的:
- 描述ICI治疗患者的神经肌肉疾病的临床和电诊断结果.
- 区分ICI诱导的神经和神经肌肉结/肌肉表型.
主要方法:
- 在ICI治疗后进行电诊断评估的38名疑似n-irAEs患者的回顾性分析.
- 将其分为两种表型:ir-神经病 (头骨/外围神经病,骨干病) 和ir-MG/肌炎 (严重肌和/或肌炎).
- 使用运动/感觉传导研究,F波,针电磁图,单纤维电磁图,重复刺激,并唤起潜力.
主要成果:
- 这项研究包括38名患者:27名 (71%) 患有ir- MG/ myositis,11名 (29%) 患有ir- neuropathies.
- 在ir- MG/ myositis组中,表现出自发活动的肌肉炎是主要的模式.
- 在这些神经病症中,急性感官运动脱髓性多基隆性神经病是最常见的表现.
结论:
- 肌肉炎是最常见的IR-MG/肌肉炎模式,而非肌肉化多基隆性神经病则是IR-神经病的特征.
- 神经肌肉结位功能障碍经常与肌肉炎并存,在电生理学评估中可能会被忽视.
- 电诊断对于早期识别和有效管理ICI相关的神经肌肉并发症至关重要.
相关概念视频
Neuromuscular Junction And Blockade
3.6K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
3.6K
Myasthenia Gravis: Diagnostic Tests
1.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.3K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
525
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
525
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
2.1K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
2.1K
Myasthenia Gravis: Overview and Treatment
1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K
Chemical Synapses
9.1K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.1K


